Details
- Organisation Name: Princess Alexandra Hospital - Radiation Oncology Raymond Terrace (ROPART)
- HHS: Metro South
- Services Offered: Early Phase; Clinical trials site; Investigator Initiated Trials; Trial Patient Recruitment; Treatment of patients; Completion of study documentation as per ICH GCP and contract
- Website Address: www.metrosouth.health.qld.gov.au
- Contact: Jason Kelly- [email protected]
- Other Affiliated Research Sites: Mater Misericordiae Hospital; ROPAIR - Princess Alexandra Hospital Radiation Oncology; Queensland Children's Hospital; Princess Alexandra Hospital Clinical Trials Unit
Location
-27.49737 - 153.03352
Initiating study activities approval
No
Review required
2 weeks
Site Overview
The Cancer Trials Unit of the Princess Alexandra Hospital is dedicated to providing a high quality service for the delivery of clinical research treatments for patients with cancer. The research conducted explores questions of optimal drug use; novel combination chemotherapies; targeted therapies; radiation therapy; new diagnostic tests; prognostic indices; best supportive care; molecular predictors of response and cost effectiveness. The aims of the Cancer Trials Unit are to offer patients with cancer access to new treatments or treatments that would be otherwise unavailable to them; and to contribute answers to important scientific questions to the cancer care community.
HREC
- HREC Committee Name: Metro South HHS HREC
- Meeting frequency: Monthly
- Types of HREC (IRB/ERB/ETHICS) Committee that are used: Local; Central Acting as Local
- Mandate distribution of safety: Yes
- Meeting frequency: Monthly
- Types of HREC (IRB/ERB/ETHICS) Committee that are used: Local; Central Acting as Local
- Mandate distribution of safety: Yes
Equipment
- Investigational Product: Vertical laminar flow hood (chemo/hazardous drugs), Horizontal laminar flow hood (non-hazardous drug preparation)
- Centrifuge: Yes
- Refrigerated Centrifuge: Yes
- Centrifuge: Yes
- Refrigerated Centrifuge: Yes
Patient Records
- Record Archiving: Yes
- EMR/EHR systems: In-house system
- Has your Clinical Trial Site or Service been accredited? N/A
- Audit Type: N/A
- EMR/EHR systems: In-house system
- Has your Clinical Trial Site or Service been accredited? N/A
- Audit Type: N/A
Investigational product storage Capabilities
- Refrigerator (2 to 8 Degrees C): Yes
- Freezer (-20 to -30 Degrees C): Yes
- Investigational Freezer (-70 to -80 Degrees C): Yes
- Investigational Freezer (Liquid Nitrogen -135 Degrees C): No
- Does this equipment have back-up power? Yes
- Does this equipment provide Min/Max Temperature Monitoring? Yes
- Do you have the ability to generate a temperature monitoring log for this equipment? Yes
- Does this equipment have a temperature alarm? Yes
- Do you have an SOP which supports calibration of this equipment? Yes
- Freezer (-20 to -30 Degrees C): Yes
- Investigational Freezer (-70 to -80 Degrees C): Yes
- Investigational Freezer (Liquid Nitrogen -135 Degrees C): No
- Does this equipment have back-up power? Yes
- Does this equipment provide Min/Max Temperature Monitoring? Yes
- Do you have the ability to generate a temperature monitoring log for this equipment? Yes
- Does this equipment have a temperature alarm? Yes
- Do you have an SOP which supports calibration of this equipment? Yes
Specialty Research Area
Male Urogenital Diseases
Neoplasms
Oncology
Radiation
Respiratory Tract Diseases
Study Types
Academic
Industry
Investigator
Average time to start study (in calendar days)
30-60
How long prior to HREC meeting does the application need to be submitted?
2 weeks
Support in-patient admissions
Yes
PK & PD specimens
Yes
Study Phase Capability
Phase I
Phase II
Phase III
Patient Population
Paediatrics
Adolescents/Adults 16 and onwards
Adults 18 and onwards
Geriatrics 65 and onwards